Skip to content
Life Sciences Series B Founded 2021

Cellinfinity Bio

Developer of cell therapies for cancer treatment

📍 West Haven, United States · Oncology

Funding snapshot

Last roundSeries B
Amount$400K
Date8 January 2025

About

Developer of cell therapies for cancer treatment. It offers genetically engineered T cell, NK cell, and other immune cell-based therapies against multiple malignancies which includes solid tumors.

Latest news

No articles yet.

Raising like Cellinfinity Bio?

Analyze your pitch deck before your next raise.

Analyze My Deck →